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SUMMARY
The first cord blood bank in the British Isles was established in Belfast in June 1993. Cord blood
(CB) is rich in haematopoietic progenitor cells and has been used successfully as a substitute for
bone marrow transplants in over 200 patients world-wide. Most have received CB from a
histocompatible sibling, but reports include several unrelated HLA matched transplants. In
addition to the cryopreservation of 400 units of donated CB in the Cord Blood Bank, we have
stored eight CB collections from siblings ofchildren with leukaemia in Northern Ireland. A pilot
study in collaboration with the maternity unit in the Mater Infirmorum Hospital confirmed the
feasibility of a CB banking programme and highlighted many issues relating to Good
Manufacturing Practice (GMP). The authors describe experience of collecting 824 units of CB
overthree years and discuss afew ofthe widerimplications ofthis innovation in themanagement
of patients requiring myeloablative therapy.
INTRODUCTION
Umbilical Cord Blood (CB) is a source of
haematopoietic stem cells which can be used as
analternativetobonemarrowfortransplantation.I
SincethefirstreportofasuccessfulCBtransplant2
morethan200childrenandadultswithcongenital
or malignant diseases have received histo-
compatible CB from a sibling or storedunrelated
HLA-matched CB. TheBelfast CordBloodBank
is based within the Northern Ireland Blood
Transfusion Service (NIBTS) and consists of
dedicated siblingdonations forspecifiedpatients
and unrelated donations for general use.
SIBLING DONATIONS
Thereisgeneralagreementamonghaematologists
and oncologists that cord blood from a sibling
must be cryopreserved if an older child in the
family is known to suffer from a disease which is
normally treated with bone marrow
transplantation.3 Many CB transplants carried
outtodatehaveusedsiblingcollections. Wehave
received requests from the paediatric
haematologist for collection ofCB from siblings
ofninepatientswithleukaemiawhentheirmothers
have become pregnant. Such sibling collections
can be arranged in any hospital where delivery is
scheduled. Theobstetricianinchargeiscontacted
and at least two midwives are trained in the
collection procedure, with emphasis on the
importance of sterile techniques and accurate
documentation. To date, nine sibling collections
have been cryopreserved from eightpregnancies
(one mother had twins). So far it has not been
deemed clinically necessary to use any of the
stored units for transplant.
UNRELATEDDONATIONS: INFORMEDCONSENT
Information is provided to pregnant women by
midwives and obstetricians towards the end of
pregnancy. In consenting to CB banking, the
mother agrees that the collection will not be
reserved for any member of her family. At
antenatalclinics, mothersaregivenaleafletwhich
explains the Cord Blood Bank and the use ofCB
as an alternative to donated bone marrow in
medical treatment. The obstetrician or midwife
discusses the programme with the mother,
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answering any queries. The leaflet contains a
consent form: the mothergives herwritten consent
to the collection ofCB post-partum and consents
to provide blood samples for all mandatory tests.
The mother is assured thatblood is nottaken from
the baby.
COLLECTION OF CORD BLOOD
Normal obstetric practice is not altered in any
way for purposes of CB collection. The
obstetrician is in charge of the collection
procedure and the actual collection is performed
by midwives with the placenta in utero. Midwives
are trained by a member of NIBTS staff. After
delivery, the cord is clamped and cut, and using
appropriate aseptic techniques the umbilical vein
is punctured. We use standard blood collection
sets incorporating abagcontaining anticoagulant,
sterile tubing and a needle which is used to pierce
the umbilical vein; blood is allowed to drain into
the bag under gravity.
In addition to sterile collection ofthe CB, a small
sample is milked from the cord into a tube for use
as an archive serum sample. A venous sample is
collected from the mother for microbiology tests.
Midwives complete formstoprovide the mother's
details and those of the birth. Thorough
documentation oftheCB donation is meticulously
carried out during collection and processing of
samples. Unique barcode labels are affixed to all
samples and to the CB pack. These labels are
specific for each collection and are an integral
part of the documentation system for the CB
donations. Any labels that remain unused are
returned to NIBTS with the collection.
PROCESSING OF CORD BLOOD COLLECTIONS
CB is transported each morning from maternity
units to NIBTS under the strictly controlled
conditions which we use for blood and blood
products. At NIBTS all details are recorded and
3 ml CB is removed under sterile conditions from
the blood pack using a needle and syringe. This
sample is used for ABO and Rhesus grouping,
HLA typing, bacterial cultures and nucleated cell
counts.
The remaining CB in the pack is mixed with an
equal volume of cryodiluent prior to freezing.
The cryodiluent consists of sterile dimethyl
sulphoxide (DMSO) and albumin in a ratio of
1:4; this protects the integrity of the stem cells.
DMSO is exothermic and care is taken to add
chilled cryodiluent slowly to GB with continuous
mixing. The final mixture for freezing is double
the volume of the CB and contains DMSO at a
concentration of 10%. The CB/cryodiluent
mixture in a freezing bag is placed between metal
plates and frozen in a controlled rate freezer to a
temperature of-I00°C. Subsequently, the frozen
packs are transferred to liquid nitrogen tanks
where they are stored in the vapour phase.
RESULTS
A total of 824 units of CB were collected, of
which 186 are available for unrelated
transplantation and the remaining collections are
used forvalidation, quality assurance procedures
and development of improved techniques for
storage. There is a wide range in the volume
collected (12.5 to 189ml) with a median of 72ml
(Fig. 1). The range in mononuclear cell (MNC)
numbers was 0.3 to 18. 1 x 108/unit with a median
MNC of 3.1 x 108/unit (Fig. 2). Total nucleated
cell numbers were also assessed: the range was
0.1 to 33 x 108/unit,with a median of 7.1 x 108/
unit (Fig. 3).
Figure 1: Volume of CB excluding anticoagulant
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Figure 2: Total mononuclear cell count
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Figure 3: Total nucleated cell count
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Microbiological screening for mandatory tests
includeHepatitis B,HepatitisC, HIVandsyphilis;
no positive results were obtained in the 186
collections for which consent for banking was
obtained. The bacteriological contamination rate
wassignificant(12.8%)duringtheearly stagesof
the programme with a brief period when the
infection rate was greater than 20%. There was a
marked reduction in contamination (4.2%) after
midwives were trained in sterile procedures. The
organisms cultured were streptococci,
staphylococci (including coagulase negative
strains), bacteroides, enterococcusfaecalis and
proprionibacterium spp.
STORAGEANDRETRIEVALOFCBCOLLECTIONS
Documentation is necessary when dealing with
blood and blood products and the routine
procedures used in NIBTS are extended to CB
banking. Identification and accrual of all
informationrelatingtotestsandsubsequentresults
ofHLAtypingcanbecollatedforeach specimen.
Each collection is labelled with aunique barcode
number, dateoffreezingandvolume. Thespecial
labels must withstand thefreezing procedure and
are licensed for use in liquid nitrogen tanks.
Archiveinformationincludesthepositionofeach
bagandsamplesothatrapidandaccurateretrieval
is assured.
DISCUSSION
CB has ahigherconcentration ofhaematopoietic
progenitorcellsthanbonemarrow4. Furthermore,
partiallymismatchedCB canbeusedsuccessfully5
and the incidence of graft-versus-host-disease
appears to be infrequent. This is attributed to the
immunological naivety ofcells in CB. Ithas been
estimatedthatapproximately40%oonlyofpatients
whorequire bone marrow transplantation receive
it. Several factors such as a lack ofidentical HLA
matched donors, inability to trace volunteers on
the bone marrow donor panel and relapse of
diseaseduringthedelayinidentifyingandtesting
suitabledonorshavebeenrecognisedbyclinicians
as unsatisfactory6. An "off-the-shelf' supply of
cryopreserved ("banked") CB will increase the
availability of stem cell transplants for patients
who require it as part oftheir management. This
is confirmed by the experience in the USA where
recent figures indicate that approximately 25%
of all unrelated stem cell transplants are from
cord blood (Rubinstein, personal com-
munication).
The European Organisation for Cord Blood
Banking proposes to collect and store 20,000 CB
units in Europe in the next 2-3 years and this will
enableus toevaluate theclinicaloutcome ofsuch
a programme'. The Belfast Cord Blood Bank is
part of this collaborative venture and one of the
authors (Chitra Bharucha) is co-ordinator for
standardisation of CB banking in Europe. The
aim is to store 1000-3000 units ofCB in each of
the participating centres and to share HLA data
withaccess tocompatible units. Inthemeantime,
all the centres are developing techniques for
volume reduction of CB for storage without
compromising viability of stem cells because of
theconsiderableresourceimplicationsassociated
withliquidnitrogenstorageofsuchalargenumber
of blood bags.
There is no standardisation of processing
proceduresortestsperformedindifferentcentres.
Reported results indicate that there is correlation
between speed of engraftment and "white cell
count" (WBC), "total nucleated cell count"
(TNC), "mononuclear cell count" (MNC), CD34
cell count and haemopoietic progenitor colony
count. However, these parameters do notprovide
a uniform accurate determination of stem cell
content because of the variation in techniques.
Therefore, analyses of clinical results show a
wide variation in the optimum CB collection,
with one study5 concluding that a minimum of
1 x 106 TNC/kg is required for engraftment and
anotherstudycites3.7 x 107nucleatedcelldosekg.
(Eliane Gluckman, personal communication).
A pilot study initiated in NIBTS in 19937
established the feasibility of the collection
procedures and banking programme, and
highlightedissuesofgoodmanufacturingpractice
(GMP) which have been incorporated into our
routine procedures. The wide range in volume
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andmononuclearcells is wellrecognised8 andthe
obstetric factors influencing their recovery have
been analysed9. The superior engraftment
potential and good correlation between volume
and MNC concentration make it possible to
identify a minimum volume for storage. There
are approximately 20,000 deliveries per annum
in Northern Ireland. At present, it is necessary to
be selective for CB banking and two maternity
unitshavebeentargetedfortraininginprocedures
which comply with GMP requirements. We
process and cryopreserve CB collections which
are greater than 70ml in volume and have been
transportedtoNIBTS within48hoursofdelivery.
The fact that a significant number of CB stem
cells are pluripotent haematopoietic cells makes
genetic modification and ex vivo expansion
possible areas of enormous potential for gene
therapy in the future. Commercial companies
havebeenquickinrecognisingfuturepossibilities,
and several companies, at least one of them in
Ireland, havebeguntoexploitpatientsbyoffering
to store CB indefinitely for an annual fee. This is
highly undesirable. Furthermore, there is
increasing recognition by the Department of
Health and Social Services thatCB banking must
not be allowed to develop in an unplanned and
haphazardmannerallovertheUK. Wearehopeful
that funding and procedures for planned further
development and extension of the Belfast Cord
Blood Bank will be implemented soon.
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